Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Top Story
Collaboration
Astellas and Poseida to collaborate on oncology cell therapies
Poseida Therapeutics and Astellas, under its Xyphos Biosciences subsidiary, have initiated a research collaboration and licensing agreement to develop allogeneic cell therapy programs by combining their innovative cell therapy platforms and technologies.
Featured
Diagnostic Technologies
FDA said no to proficiency testing for LDT quality
FDA Clearance
Leica Biosystems, Sectra receive FDA 510(k) clearance for digital pathology system
Latest News
FDA releases LDT final rule
April 29, 2024
Sponsored
Visit our Molecular Diagnostics Community
April 5, 2024
Study: Age-related differences in nasal cells offer COVID-19 protection
April 29, 2024
Pillar Biosciences gets FDA approval for NGS solid tumor profiling test
April 26, 2024
Business Insights
Diagnostic Technologies
FDA said no to proficiency testing for LDT quality
FDA Clearance
Leica Biosystems, Sectra receive FDA 510(k) clearance for digital pathology system
Pathology and AI
Quest Diagnostics to add digital pathology lab, AI pathology center in Tennessee
Policy and Regulation
FDA releases LDT final rule
Diagnostic Technologies
Policy and Regulation
FDA releases LDT final rule
FDA Clearance
Pillar Biosciences gets FDA approval for NGS solid tumor profiling test
Sequencing
Mission Bio launches new features for Tapestri platform
Gene silencing and gene editing
Engineered Cas clears barrier to antiviral CRISPR therapies
Diseases
COVID-19
Study: Age-related differences in nasal cells offer COVID-19 protection
Validation
Immunovia announces positive results for next-gen pancreatic cancer test
Collaboration
Vertex to pay $25M upfront to scale cell manufacturing technology
Point-of-Care Testing
Scout secures CARB-X grant to advance diagnostic test development
More from LabPulse.com
Quest Diagnostics to add digital pathology lab, AI pathology center in Tennessee
By
LabPulse.com staff writers
Quest Diagnostics said it will acquire PathAI Diagnostics in Memphis, TN, the business of PathAI that provides anatomic and digital pathology laboratory services, to accelerate the adoption of digital and AI pathology.
May 1, 2024
Variantyx raises $36M in funding
By
LabPulse.com staff writers
Precision molecular diagnostics firm Variantyx has raised $36 million in a recent funding round, bringing the total funding that Variantyx has raised to more than $125 million.
April 30, 2024
Immunovia announces positive results for next-gen pancreatic cancer test
By
LabPulse.com staff writers
Diagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.
April 25, 2024
Vertex to pay $25M upfront to scale cell manufacturing technology
By
LabPulse.com staff writers
As part of the deal, Vertex was also willing to pay up to $215 million in milestones achieved in connection with the development of a scaled-up process for fully differentiated islet cells.
April 25, 2024
Labcorp buys Invitae portfolio for $239M
By
LabPulse.com staff writers
Labcorp was the winning bidder in the court-supervised auction of Invitae's assets, obtaining substantially all of the San Francisco-based company's business for $239 million in cash consideration with other noncash consideration.
April 26, 2024
Bristol Myers Squibb to reduce workforce in restructuring plan
By
LabPulse.com staff writers
As part of a restructuring plan intended to cut $1.5 billion in costs, Bristol Myers Squibb plans to cut about 6% of its workforce, according to the firm.
April 25, 2024
U.K. Patents Court rules Bio-Techne patents invalid in infringement lawsuit
By
LabPulse.com staff writers
The Patents Court of the High Court of England and Wales has ruled that two patents owned by Bio-Techne are invalid, rejecting a patent infringement lawsuit filed by Bio-Techne/ACD in the U.K. against Molecular Instruments.
April 24, 2024
Scout secures CARB-X grant to advance diagnostic test development
By
LabPulse.com staff writers
Scout, formerly Uh Oh Labs, will advance its point-of-care (POC) diagnostic test for sexually transmitted infections (STIs) with a new $1 million accelerator grant.
April 22, 2024
Mission Bio launches new features for Tapestri platform
By
Matt Limb
Mission Bio has launched new multiplexing features for its Tapestri platform, saying they will make single-cell technology more affordable and accessible to the biomedical community.
April 24, 2024
Quest adds new biomarker test to Alzheimer's portfolio
By
LabPulse.com staff writers
Quest Diagnostics has launched a new blood biomarker test as part of its AD-Detect portfolio of blood tests for Alzheimer's disease risk assessment.
April 23, 2024
Bio-Techne files EU patent infringement suit against Molecular Instruments
By
LabPulse.com staff writers
Life sciences company Bio-Techne has filed a lawsuit against Molecular Instruments in the pan-European Unified Patent Court, alleging patent infringement of its RNAscope in situ hybridization technology.
April 23, 2024
Target ALS launches new data portal for research
By
Matt Limb
A nonprofit medical research foundation has launched a data portal designed to help spur scientific breakthroughs for the disease amyotrophic lateral sclerosis (ALS).
April 23, 2024